Aprea Therapeutics Stock Forecast

Sell candidate since Jul 16, 2026 Loss -10.14%

The Aprea Therapeutics Inc. stock price fell by -2.36% on the last day (Friday, 31st Jul 2026) from $0.635 to $0.620. During the last trading day the stock fluctuated 7.13% from a day low at $0.613 to a day high of $0.656. The price has fallen in 6 of the last 10 days and is down by -12.61% for this period. Volume has increased on the last day by 31 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 50 thousand shares were bought and sold for approximately $30.72 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -27.68% during the next 3 months and, with a 90% probability hold a price between $0.386 and $0.531 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

APRE Signals & Forecast

A buy signal was issued from a pivot bottom point on Tuesday, July 28, 2026, and so far it has risen 1.03%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Aprea Therapeutics Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.625 and $0.718. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Aprea Therapeutics Inc. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Aprea Therapeutics Inc. stock

Aprea Therapeutics Inc. finds support from accumulated volume at $0.614 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.0437 between high and low, or 7.13%. For the last week, the stock has had daily average volatility of 7.73%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (APRE) For The Upcoming Trading Day Of Monday 3rd

For the upcoming trading day on Monday, 3rd we expect Aprea Therapeutics Inc. to open at $0.630, and during the day (based on 14 day Average True Range), to move between $0.593 and $0.647, which gives a possible trading interval of +/-$0.0545 (+/-9.19%) up or down from last closing price. If Aprea Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 9.19% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $0.621 (0.16%) than the support at $0.614 (1.02%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Aprea Therapeutics Inc. stock A Buy?

Aprea Therapeutics Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -2.604 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on August 3, 2026 - $0.630 ( 1.56%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk